Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-09

FDA Approved: FEBUXOSTAT — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Febuxostat submitted by Sun Pharmaceutical Industries, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEBUXOSTAT (Febuxostat)

Snippet

SUPPL AP for FEBUXOSTAT (FEBUXOSTAT)